BG51774A1 - Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide - Google Patents

Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide

Info

Publication number
BG51774A1
BG51774A1 BG9288590A BG9288590A BG51774A1 BG 51774 A1 BG51774 A1 BG 51774A1 BG 9288590 A BG9288590 A BG 9288590A BG 9288590 A BG9288590 A BG 9288590A BG 51774 A1 BG51774 A1 BG 51774A1
Authority
BG
Bulgaria
Prior art keywords
basedon
pyridylcarboxamide
benzothiazine
hydroxy
dioxide
Prior art date
Application number
BG9288590A
Inventor
Violeta Kh Andonova
Katja S Radeva
Evtimija I Velikova
Liljana N Stanoeva
Penka A Kazandzhieva
Mile V Taskov
Snezhana G Vitkova
Petar B Grigorov
Ivan Kh Radoslavov
Nevena L Firkova
Ivan A Again
Original Assignee
Bg Druzhestven N Izsledovatels
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bg Druzhestven N Izsledovatels filed Critical Bg Druzhestven N Izsledovatels
Priority to BG9288590A priority Critical patent/BG51774A1/en
Publication of BG51774A1 publication Critical patent/BG51774A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The drug agent is applied in humane medicine for treatment of rheumatic diseases, chronic polyarthrites, degenerative arthroses, etc. and has an enhanced solvency, reduced ulcerogenic action and an expressed hepatoprotective effect. It contains in weight p. piroxicam 0.005-0.030 and glycine 0.005-0.030.
BG9288590A 1990-09-21 1990-09-21 Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide BG51774A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG9288590A BG51774A1 (en) 1990-09-21 1990-09-21 Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG9288590A BG51774A1 (en) 1990-09-21 1990-09-21 Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide

Publications (1)

Publication Number Publication Date
BG51774A1 true BG51774A1 (en) 1993-09-15

Family

ID=3923262

Family Applications (1)

Application Number Title Priority Date Filing Date
BG9288590A BG51774A1 (en) 1990-09-21 1990-09-21 Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide

Country Status (1)

Country Link
BG (1) BG51774A1 (en)

Similar Documents

Publication Publication Date Title
NL300258I2 (en) Pharmaceutical composition for use in the treatment of.
DK77090A (en) Immunomodulatory AZASPIRANS
DE69521994D1 (en) COMPOSITIONS WHICH CONTAIN DNA DESTROYING AGENTS AND P53
DE58901401D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING THE DIABETES MELLITUS.
FI963424A0 (en) Process for the preparation of therapeutically active thiophenesulfonamides
DE69132688D1 (en) METHOD FOR TREATING AND PREVENTING TYPE-1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
KR930702000A (en) Use of parosetin for the treatment of old age dementia, edema, migraine headaches, or poor food
NL990011I1 (en) Azelastine containing medicines for use in the nose and / or the eye.
ITMI951359A0 (en) PHARMACEUTICAL AND DIETARY FORMULATIONS FOR THE PROPHYLAXIS AND TREATMENT OF GASTROINTESTINAL DISEASES
MX9302038A (en) METHOD FOR THE TREATMENT OF CANCER BY A JOINT THERAPY WITH 2-HALOMETILIDENO DERIVATIVES AND A SPECIFIC PHASE M OR PHASE S ANTINEOPLASIC AGENT.
IT8820073A0 (en) AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM AND PROCEDURE FOR THEIR PREPARATION.
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
ITRM920900A0 (en) PROTEIN FORMULATION ASSISTANT IN THE PREVENTION AND TREATMENT OF PERIODONTITIS AND OTHER BACTERIAL DISEASES OF THE ORAL CAVITY.
DE68926746D1 (en) ANTI-FLAMMABLE AND / OR IMMUNITY-SUPPRESSING MEDICINE-BASED MEDICINAL PRODUCTS
NL187299C (en) FORMED PHARMACEUTICAL DOSAGE UNIT FOR THE TREATMENT OF HEART AND Vascular Diseases.
ES2044170T3 (en) STRONTIUM SALT, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
BG51774A1 (en) Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
SE9000207D0 (en) MEDICINAL PRODUCTS AND THE USE OF THE SAME
DE59309732D1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT AND PROPHYLAXIS OF BONE AND JOINT DISEASES
DE69228686D1 (en) MEDICINAL PRODUCT CONTAINING PENCICLOVIR
NZ232499A (en) Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole
ES2101311T3 (en) USE OF A TRANSDERMIC DEVICE CONTAINING (E) -2- (P-FLUOROFENETIL) -3-FLUOROALILAMINA AND ITS USE FOR THE TREATMENT OF ALZHEIMER DISEASE.
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
IL105569A0 (en) Pharmaceutical compositions for the treatment of parkinson's disease